Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Confusion on warrant expiry date

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon May 13, 2022 12:37pm

180 Views

Post# 34681985

RE:RE:RE:RE:Confusion on warrant expiry date

Legit62 wrote: I dont think warrants can be extended twice, so i believe you are correct, the question is, do we know how many warrants remain and how many will expire tomorrow?

an aggregate of 5,104,000 Units i.e. including 5,104,000 warrants were issued. The exercise price on the warrants is 30 cents.

From December 2021 through April of this year the share price has managed to maintain a price slightly above the 30 cent level so presumably people may have been motivated to exercise the warrants. No idea where or who keeps count.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec